MicroRNA-214 inhibits left ventricular remodeling in an acute myocardial infarction rat model by suppressing cellular apoptosis via the phosphatase and tensin homolog (PTEN)

International Heart Journal

Volumn 57, Issue 2, 2016, Pages 247-250

  Yang, Xingwei ^a   Qin, Yanjun ^b   Shao, Suxia ^b   Yu, Yueqing ^c   Zhang, Chongyang ^a   Dong, Hua ^a   Lv, Guangwei ^d   Dong, Shimin ^b  

^a First Hospital of Qinhuangdao   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Department of Endocrinology General Hospital of Hebei Province   (China)

^d CANGZHOU CENTRAL HOSPITAL   (China)

Author keywords

Adenovirus expressing transfer; QRT PCR analysis; Rat acute myocardial model; Western blot analysis

Indexed keywords

MICRORNA 214; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; MICRORNA; MIRN214 MICRORNA,RAT; PHOSPHATASE; PTEN PROTEIN, RAT; RNA;

ACUTE HEART INFARCTION; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE REMODELING; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE CELL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEART INFARCTION; HEART VENTRICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEART VENTRICLES; MICRORNAS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; RNA; UP-REGULATION; VENTRICULAR REMODELING;

EID: 84961616473     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.15-293     Document Type: Article

References (20)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-209.
2. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res 2009; 81: 482-90. (Review)
3. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117: 568-75. (Review)
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97. (Review)
5. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005; 120: 21-4.
6. Zhu H, Fan GC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res 2012; 94: 284-92. (Review)
7. Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 2009; 284: 29514-25.
8. Qin Y, Yu Y, Dong H, Bian X, Guo X, Dong S. MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis. Int J Med Sci 2012; 9: 413-23.
9. Orenstein TL, Parker TG, Butany JW, et al. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression. J Clin Invest 1995; 96: 858-66.
10. Kolakowski S Jr, Berry MF, Atluri P, et al. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. J Card Surg 2006; 21: 559-64.
11. DiFrancesco D. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents. Curr Med Res Opin 2005; 21: 1115-22. (Review)
12. Honda T, Kanazawa H, Koga H, Miyao Y, Fujimoto K. Heart rate on admission is an independent risk factor for poor cardiac function and in-hospital death after acute myocardial infarction. J Cardiol 2010; 56: 197-203.
13. Takemura G, Fujiwara H. Role of apoptosis in remodeling after myocardial infarction. Pharmacol Ther 2004; 104: 1-16. (Review)
14. Abbate A, Biondi-Zoccai GGL, Bussani R, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 2003; 41: 753-60.
15. Rosivatz E. Inhibiting PTEN. Biochem Soc Trans 2007; 35: 257-9.
16. Sasaoka T, Wada T, Tsuneki H. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Pharmacol Ther 2006; 112: 799-809. (Review)
17. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004; 37: 449-71. (Review)
18. Sayed D, He M, Hong C, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 2010; 285: 20281-90.
19. Lv G, Shao S, Dong H, Bian X, Yang X, Dong S. MicroRNA-214 protects cardiac myocytes against H2O2-induced injury. J Cell Biochem 2014; 115: 93-101.
20. 2+ overload and cell death. J Clin Invest 2012; 122: 1222-32.